Skip to main content

Table 5 Meta-regression results

From: Diversity in randomized clinical trials for peripheral artery disease: a systematic review

Outcome/Covariate

Coefficient

p-value

Proportion of Women

 Study year

0.012

0.096

 Study location (Europe vs non-Europe)

0.059

0.032

 Population type (PAD and CLI vs PAD only)

0.013

0.77

 Trial length (years)

0.0086

0.25

 Duration of enrollment (months)

0.0003

0.84

 Number of study locations

0.0003

0.63

Mean Age of Participants

 Study year

0.187

0.46

 Study location (Europe vs non-Europe)

-0.647

0.55

 Population type (PAD and CLI vs PAD only)

0.193

0.90

 Trial length (years)

-0.035

0.90

 Duration of enrollment (months)

-0.042

0.29

 Number of study locations

0.013

0.57

  1. CLI Critical limb ischemia, PAD Peripheral artery disease